This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Clostridium difficile vaccine, IC84, IC-84, VLA-84
Description: IC84 is a recombinant protein vaccine consisting of two truncated toxins A and B from Clostridium difficile.
Deal Structure: In May 2013, Valneva announced its creation through the completion of the merger of equals between Vivalis and Intercell.
Additional information available to subscribers only: